David Hallal, CEO at ALEXION PHARMACEUTICALS INC (ALXN), sold 612 shares at $196.52 ($120K) on 2015-08-04, disclosed to the SEC on 2015-08-05.
Open-market sale of $120k ALXN by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ITOS | SELL | 2025-06-06 | $2.3M | — | Filing → |
| ALVR | SELL | 2022-10-21 | $5.1M | — | Filing → |
| ALVR | SELL | 2022-09-30 | $2.9M | — | Filing → |